Literature DB >> 903768

Carbohydrate metabolism in motor neurone disease.

D Saffer, J Morley, P L Bill.   

Abstract

Eight patients with classical motor neurone disease, and eight control patients with neurological disease and matched for degree of wasting, were studied. Both groups had abnormal glucose tolerance, but the patients with motor neurone disease had a significantly lower insulin response both to oral glucose loading and to intravenous tolbutamide. These results suggest that in patients with motor neurone disease there is an impaired synthesis or release of insulin due to islet cell damage. Blood pyruvate and lactate, and cerebrospinal fluid pyruvate, lactate, and citrate, did not differ significantly from the control group. Blood citrate levels were significantly higher in patients with motor neurone disease compared with the controls. Triglyceride levels were raised in patients with motor neurone disease compared to the control patients. This may be secondary to the increased citrate levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903768      PMCID: PMC492758          DOI: 10.1136/jnnp.40.6.533

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  STUDIES ON CARBOHYDRATE METABOLISM IN AMYOTROPHIC LATERAL SCLEROSIS AND HEREDITARY PROXIMAL SPINAL MUSCULAR ATROPHY.

Authors:  V Ionǎşescu; N Luca
Journal:  Acta Neurol Scand       Date:  1964       Impact factor: 3.209

2.  THE ASSOCIATION OF AMYOTROPHIC LATERAL SCLEROSIS (MOTOR NEURON DISEASE) AND CARBOHYDRATE INTOLERANCE, A CLINICAL STUDY.

Authors:  J STEINKE; H R TYLER
Journal:  Metabolism       Date:  1964-11       Impact factor: 8.694

3.  Biochemical aspects.

Authors:  J N CUMINGS
Journal:  Proc R Soc Med       Date:  1962-12

4.  A micromethod for the determination of serum triglycerides.

Authors:  G YOUNG; R EASTMAN
Journal:  S Afr J Lab Clin Med       Date:  1963-03

5.  A simplified method for the determination of citric acid.

Authors:  E BEUTLER; M K YEH
Journal:  J Lab Clin Med       Date:  1959-07

6.  Discussion on some clinical, genetic and biochemical aspects of metabolic disorders of the nervous system: metabolic disease of the nervous system: clinical aspects.

Authors:  W B MATTHEWS
Journal:  Proc R Soc Med       Date:  1958-10

7.  Determination of amylase activity in biological fluids.

Authors:  H V STREET; J R CLOSE
Journal:  Clin Chim Acta       Date:  1956 May-Jun       Impact factor: 3.786

8.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

9.  Glucose metabolism in five neuromuscular disorders.

Authors:  W J Collis; W K Engel
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

10.  Abnormal insulin secretion in amyotrophic lateral sclerosis.

Authors:  F Goto; A Kitamura; A Koto; K Kataoka; H Atsuji
Journal:  J Neurol Sci       Date:  1972-06       Impact factor: 3.181

View more
  5 in total

1.  SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism.

Authors:  Susan E Smittkamp; Jill K Morris; Gregory L Bomhoff; Mark E Chertoff; Paige C Geiger; John A Stanford
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

2.  Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis.

Authors:  J Dorst; P Kühnlein; C Hendrich; J Kassubek; A D Sperfeld; A C Ludolph
Journal:  J Neurol       Date:  2010-12-03       Impact factor: 4.849

3.  Plasma citrate in motor neuron disease.

Authors:  S T Vilming
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

4.  TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets.

Authors:  Kunihiko Araki; Amane Araki; Daiyu Honda; Takako Izumoto; Atsushi Hashizume; Yasuhiro Hijikata; Shinichiro Yamada; Yohei Iguchi; Akitoshi Hara; Kazuhiro Ikumi; Kaori Kawai; Shinsuke Ishigaki; Yoko Nakamichi; Shin Tsunekawa; Yusuke Seino; Akiko Yamamoto; Yasunori Takayama; Shihomi Hidaka; Makoto Tominaga; Mica Ohara-Imaizumi; Atsushi Suzuki; Hiroshi Ishiguro; Atsushi Enomoto; Mari Yoshida; Hiroshi Arima; Shin-Ichi Muramatsu; Gen Sobue; Masahisa Katsuno
Journal:  J Clin Invest       Date:  2019-07-29       Impact factor: 14.808

Review 5.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.